BioRestorative Therapies, Inc.
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
BRTX$1.60+5.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference | ||||
|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Form | Exhibit | Filing Date |
| 3.1 | Amended and Restated Articles of Incorporation | 8-K | 3.3 | 1/5/2023 |
| 3.2 | Certificate of Designations of Preferred Stock (Series B) | 8-K | 3.4 | 1/5/2023 |
| 3.3 | Bylaws | 8-K | 3.5 | 1/5/2023 |
| 31.1* | Certification of Principal Executive Officer | |||
| 31.2* | Certification of Principal Financial Officer | |||
| 32.1** | Section 1350 Certification of Principal Executive Officer and Principal Financial Officer | |||
| 101.INS | Inline XBRL Instance Document | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||
| 104 | Cover Page Interactive Date File (embedded within the Inline XBRL document) | |||
| * | Filed herewith. |
|---|---|
| ** | In accordance with SEC Release 33-8238, Exhibit 32.1 is being furnished and not filed. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.